Clinical Trial Update: SGLT2-Inhibitors for Sleep Apnea in Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SGLT2 inhibitors for sleep apnea in heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sleep Apnea

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Columbia University | Conditions: Heart Failure, Sleep Disordered Breathing | Phase 2 | Status: WITHDRAWN